PETMED EXPRESS, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
PETMED EXPRESS, INC. (PETS) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $60.11 million for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-01-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-01-30
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $60.11M, a 13.70% increase year-over-year.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $66.71M, a 9.74% increase year-over-year.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $79.66M, a 9.89% increase year-over-year.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $63.03M, a 13.79% increase year-over-year.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $249.18M, a 6.18% increase from fiscal 2016.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $234.68M, a 2.31% increase from fiscal 2015.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $229.40M, a 1.71% decline from fiscal 2014.
- PETMED EXPRESS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $233.39M, a 2.44% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $60.11M 10-Q · filed 2018-01-30 | $126.82M derived: sum of 2 quarters · filed 2018-01-30 | $206.48M 10-Q · filed 2018-01-30 | $269.51M derived: sum of 4 quarters · filed 2018-01-30 |
| 2017-09-30 | $66.71M 10-Q · filed 2017-10-31 | $146.37M 10-Q · filed 2017-10-31 | $209.40M derived: sum of 3 quarters · filed 2017-10-31 | $262.27M derived: sum of 4 quarters · filed 2018-01-30 |
| 2017-06-30 | $79.66M 10-Q · filed 2017-07-31 | $142.69M derived: sum of 2 quarters · filed 2017-07-31 | $195.56M derived: sum of 3 quarters · filed 2018-01-30 | $256.35M derived: sum of 4 quarters · filed 2018-01-30 |
| 2017-03-31 | $63.03M 10-K · filed 2017-05-23 | $115.90M derived: sum of 2 quarters · filed 2018-01-30 | $176.69M derived: sum of 3 quarters · filed 2018-01-30 | $249.18M 10-K · filed 2017-05-23 |
| 2016-12-31 | $52.87M 10-Q · filed 2018-01-30 | $113.66M derived: sum of 2 quarters · filed 2018-01-30 | $186.14M 10-Q · filed 2018-01-30 | $241.54M derived: sum of 4 quarters · filed 2018-01-30 |
| 2016-09-30 | $60.79M 10-Q · filed 2017-10-31 | $133.28M 10-Q · filed 2017-10-31 | $188.67M derived: sum of 3 quarters · filed 2017-10-31 | $239.60M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $72.49M 10-Q · filed 2017-07-31 | $127.88M derived: sum of 2 quarters · filed 2017-07-31 | $178.81M derived: sum of 3 quarters · filed 2017-07-31 | $235.54M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-03-31 | $55.39M 10-K · filed 2017-05-23 | $106.33M derived: sum of 2 quarters · filed 2017-05-23 | $163.05M derived: sum of 3 quarters · filed 2017-05-23 | $234.68M 10-K · filed 2017-05-23 |
| 2015-12-31 | $50.93M 10-K · filed 2017-05-23 | $107.66M derived: sum of 2 quarters · filed 2017-05-23 | $179.29M 10-Q · filed 2017-01-31 | $229.29M derived: sum of 4 quarters · filed 2017-05-23 |
| 2015-09-30 | $56.73M 10-K · filed 2017-05-23 | $128.36M 10-Q · filed 2016-11-01 | $178.35M derived: sum of 3 quarters · filed 2017-05-23 | $227.64M derived: sum of 4 quarters · filed 2017-05-23 |
| 2015-06-30 | $71.63M 10-K · filed 2017-05-23 | $121.63M derived: sum of 2 quarters · filed 2017-05-23 | $170.91M derived: sum of 3 quarters · filed 2017-05-23 | $228.49M derived: sum of 4 quarters · filed 2017-05-23 |
| 2015-03-31 | $49.99M 10-K · filed 2016-05-24 | $99.28M derived: sum of 2 quarters · filed 2016-05-24 | $156.85M derived: sum of 3 quarters · filed 2016-05-24 | $229.40M 10-K · filed 2017-05-23 |
| 2014-12-31 | $49.28M 10-K · filed 2016-05-24 | $106.86M derived: sum of 2 quarters · filed 2016-05-24 | $179.40M 10-Q · filed 2016-02-02 | $228.03M derived: sum of 4 quarters · filed 2016-05-24 |
| 2014-09-30 | $57.58M 10-K · filed 2016-05-24 | $130.12M 10-Q · filed 2015-10-27 | $178.75M derived: sum of 3 quarters · filed 2016-05-24 | $228.84M derived: sum of 4 quarters · filed 2016-05-24 |
| 2014-06-30 | $72.54M 10-K · filed 2016-05-24 | $121.17M derived: sum of 2 quarters · filed 2016-05-24 | $171.26M derived: sum of 3 quarters · filed 2016-05-24 | $231.74M derived: sum of 4 quarters · filed 2016-05-24 |
| 2014-03-31 | $48.63M 10-K · filed 2015-05-22 | $98.72M derived: sum of 2 quarters · filed 2015-05-22 | $159.20M derived: sum of 3 quarters · filed 2015-05-22 | $233.39M 10-K · filed 2016-05-24 |
| 2013-12-31 | $50.09M 10-K · filed 2015-05-22 | $110.56M derived: sum of 2 quarters · filed 2015-05-22 | $184.76M 10-Q · filed 2015-01-26 | $235.88M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-09-30 | $60.48M 10-K · filed 2015-05-22 | $134.67M 10-Q · filed 2014-10-28 | $185.79M derived: sum of 3 quarters · filed 2015-05-22 | $235.40M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-06-30 | $74.19M 10-K · filed 2015-05-22 | $125.31M derived: sum of 2 quarters · filed 2015-05-22 | $174.92M derived: sum of 3 quarters · filed 2015-05-22 | $233.07M derived: sum of 4 quarters · filed 2015-05-22 |
| 2013-03-31 | $51.12M 10-K · filed 2014-05-27 | $100.73M derived: sum of 2 quarters · filed 2014-05-27 | $158.87M derived: sum of 3 quarters · filed 2014-05-27 | $227.83M 10-K · filed 2015-05-22 |
| 2012-12-31 | $49.61M 10-K · filed 2014-05-27 | $107.75M derived: sum of 2 quarters · filed 2014-05-27 | $176.71M 10-Q · filed 2014-01-31 | $232.63M derived: sum of 4 quarters · filed 2014-05-27 |
| 2012-09-30 | $58.15M 10-K · filed 2014-05-27 | $127.10M 10-Q · filed 2013-10-29 | $183.02M derived: sum of 3 quarters · filed 2014-05-27 | $233.55M derived: sum of 4 quarters · filed 2014-05-27 |
| 2012-06-30 | $68.95M 10-K · filed 2014-05-27 | $124.88M derived: sum of 2 quarters · filed 2014-05-27 | $175.40M derived: sum of 3 quarters · filed 2014-05-27 | $233.63M derived: sum of 4 quarters · filed 2014-05-27 |
| 2012-03-31 | $55.92M 10-K · filed 2013-05-28 | $106.45M derived: sum of 2 quarters · filed 2013-05-28 | $164.67M derived: sum of 3 quarters · filed 2013-05-28 | $238.25M 10-K · filed 2014-05-27 |
| 2011-12-31 | $50.52M 10-K · filed 2013-05-28 | $108.75M derived: sum of 2 quarters · filed 2013-05-28 | $182.33M 10-Q · filed 2013-01-29 | $233.24M derived: sum of 4 quarters · filed 2013-05-28 |
| 2011-09-30 | $58.23M 10-K · filed 2013-05-28 | $131.80M 10-Q · filed 2012-10-31 | $182.71M derived: sum of 3 quarters · filed 2013-05-28 | $227.83M derived: sum of 4 quarters · filed 2013-05-28 |
| 2011-06-30 | $73.58M 10-K · filed 2013-05-28 | $124.49M derived: sum of 2 quarters · filed 2013-05-28 | $169.61M derived: sum of 3 quarters · filed 2013-05-28 | $230.85M derived: sum of 4 quarters · filed 2013-05-28 |
| 2011-03-31 | $50.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-28 | $96.03M derived: sum of 2 quarters · filed 2013-05-28 | $157.27M derived: sum of 3 quarters · filed 2013-05-28 | $231.64M 10-K · filed 2013-05-28 |
| 2010-12-31 | $45.12M 10-Q · filed 2012-01-31 | $106.36M derived: sum of 2 quarters · filed 2012-01-31 | $180.73M 10-Q · filed 2012-01-31 | |
| 2010-09-30 | $61.24M 10-Q · filed 2011-11-01 | $135.61M 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | $74.37M 10-Q · filed 2011-08-02 | |||
| 2010-03-31 | $238.27M 10-K · filed 2012-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |